Manipal Health Enterprises has raised ₹4,167 crore from anchor investors at the upper end of its IPO price band, securing strong institutional backing days ahead of its proposed public issue, which targets a total fundraising of approximately ₹9,275 crore.

The anchor allocation, representing roughly 45% of the total IPO size, is a standard mechanism in Indian initial public offerings that allows companies to allot shares to institutional investors before the public subscription period opens. It is often viewed as an early indicator of demand from large financial institutions and typically sets the tone for retail and non-institutional subscription in the days that follow.

Use of Proceeds

According to the company's IPO plan, a significant portion of the fresh issue proceeds will be directed toward the following purposes:

• Debt reduction: Lowering the hospital chain's outstanding borrowings to strengthen its balance sheet.
• Acquisition of a minority stake in Sahyadri Hospitals: Expanding Manipal's footprint through a strategic investment in the Pune-based hospital network, which would deepen its presence in the Maharashtra healthcare market.
• General corporate purposes: Supporting ongoing operational and strategic requirements.

Company Background

Manipal Health Enterprises, headquartered in Bengaluru, is one of India's largest private healthcare providers, operating a multi-specialty hospital network across multiple states. The company's proposed listing would place it alongside publicly traded hospital peers such as Apollo Hospitals, Max Healthcare, and Narayana Hrudayalaya, giving investors a broader set of options in India's listed hospital sector.

The IPO adds to a broader wave of healthcare-sector public offerings in India, as hospital operators seek capital to expand capacity, reduce leverage, and pursue acquisitions in a market characterized by rising demand for tertiary care, increasing health insurance penetration, and growing medical tourism.

Source: CNBC-TV18